| 12531 HIGH BLUFF DRIVE SUITE 100 SAN DIEGO, CALIFORNIA 92130-2040
TELEPHONE: 858.720.5100 FACSIMILE: 858.720.5125
WWW.MOFO.COM | MORRISON & FOERSTER LLP
NEW YORK, SAN FRANCISCO, LOS ANGELES, PALO ALTO, SAN DIEGO, WASHINGTON, D.C.
NORTHERN VIRGINIA, DENVER, SACRAMENTO, WALNUT CREEK
TOKYO, LONDON, BEIJING, SHANGHAI, HONG KONG, BRUSSELS | ||
May 11, 2010 | Writer’s Direct Contact 858.720.7912 njensen@mofo.com |
Via Edgar
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, DC 20549
Attention: Celia Soehner, Staff Attorney
Re: | Inovio Biomedical Corporation |
Form 10-K for the fiscal year ended December 31, 2009 |
Filed on March 26, 2010 |
File No. 001-14888 |
Ladies and Gentlemen:
As mentioned in my message to you, Inovio Biomedical Corporation is diligently working on its response to the letter of comment from the staff of the Securities and Exchange Commission dated April 28, 2010, and expects to file such response on or before May 20, 2010.
Please contact me at (858) 720-7912 if you have any questions. Thank you.
Sincerely,
/s/ J. Nathan Jensen
J. Nathan Jensen
cc: Peter Kies (Inovio Biomedical Corporation)